Harmony Biosciences Holdings Inc. (HRMY) Social Stream
HARMONY BIOSCIENCES HOLDINGS INC (HRMY) Price Targets From Analysts
Use the tables below to see what analysts covering HARMONY BIOSCIENCES HOLDINGS INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 116 days, HRMY's average price target has gone up $4.08.
Over the past 38 weeks, HRMY's average upside potential has been 36.71%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
HRMY Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 153 days, HRMY's average broker recommendation rating worsened by 0.35.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how HARMONY BIOSCIENCES HOLDINGS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -55.02% of that group.
- HARMONY BIOSCIENCES HOLDINGS INC's upside potential (average analyst target price relative to current price) is higher than 177.71% of Pharmaceutical Products stocks.
- HARMONY BIOSCIENCES HOLDINGS INC's average analyst price target is higher than 900.96% of Pharmaceutical Products stocks.
- HRMY has a higher number of analysts covering the stock than 457.46% of stocks in the mid market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to HARMONY BIOSCIENCES HOLDINGS INC are HCM, GBT, and FOLD.
Make investment decisions regarding HRMY using the data that counts. Try POWR Ratings for free.